Madrigal Pharmaceuticals
MDGL
MDGL
318 hedge funds and large institutions have $7.82B invested in Madrigal Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 108 increasing their positions, 91 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
318
Holders Change
+36
Holders Change %
+12.77%
% of All Funds
4.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
73
Increased
108
Reduced
91
Closed
32
Calls
$346M
Puts
$164M
Net Calls
+$182M
Net Calls Change
+$149M
Top Buyers
| 1 |
Holocene Advisors
New York
|
+$129M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$56.9M |
| 3 |
Morgan Stanley
New York
|
+$55.1M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.8M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$38.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$71.5M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$38.9M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$32.6M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$30.9M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$29.3M |
